Anya Polytech & (ANYA)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 29.07% shows the business is expanding its top line.
• ROCE of 14.22% suggests existing capital is generating a reasonable return.
• Promoter holding of 65.40% aligns management with minority shareholders in ownership.
• Latest quarter is still profitable: ₹98 Cr sales with ₹6 Cr net profit.

Concerns

• Profit growth is -23.54% despite 29.07% sales growth; margins are being squeezed.
• P/E of 36.95 is expensive for a fertilizer company whose earnings are declining.
• Piotroski F-Score of 4/9 indicates weak financial health and recovery is not assured.
• Zero dividend yield gives investors no cash return, while book value and debt/equity data are missing.

AI Analysis

Let me begin with what I can see. Anya Polytech & operates in fertilizers, a business where the product is largely commoditised and pricing is often influenced by government policy and global input costs. That immediately lowers my circle of confidence. The company has grown sales by 29.07%, which sounds nice, but net profit fell 23.54%. In my experience, revenue without profit is vanity. The latest quarter tells the same story: ₹98 crore of sales produced only ₹6 crore of net profit, a margin near 6%. A cyclically profitable company can look okay in good times, but this is happening while earnings are declining. The valuation bothers me. At ₹17.45, the market cap is ₹233 crore and the trailing P/E is 36.95. For a fertilizer company with falling profits, I need a large discount, not a premium. The PEG of 1.27 assumes the recent profit decline will reverse and turn into matching growth, but I don't have evidence of that. The Piotroski F-Score of 4 out of 9 is a warning light, not a green light. ROCE of 14.22% is acceptable but not exceptional for a capital-intensive commodity industry. There is no dividend, so the minority shareholder must rely entirely on management reinvesting wisely. I do note promoter holding of 65.40%. That can be positive if it means owners are aligned with the company. But with no dividend and weak profitability, I want to see how that capital is being deployed. The 52-week range is ₹14.50 to ₹19.95; at ₹17.45 I see no margin of safety. In the words of Graham, price is what you pay, value is what you get. Here I cannot calculate book value or debt-to-equity because the data is missing. Without that, I cannot honestly say what this business is worth. I will watch it, but I will not buy it at this price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer